Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Skin
29. May 2026
Search
medline.ch
Skin
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 7150
Articles 1 - 20 / 142992
Revisiting Thoracic Duct Resection in Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis and Immunologic Insight Into Recurrence Risk.
Thorac Cancer
Zhang X, Liu XY, Lv YJ, Li SN, Ao Y, Zhong LQ, Hu Y.
PMID: 42206574 [PubMed - indexed for MEDLINE]
Amelanotic choroidal melanoma mimicking central serous chorioretinopathy: a diagnostic challenge.
Eye (Lond)
Meng Y, Li J, Li T.
PMID: 42203985 [PubMed - as supplied by publisher]
Effectiveness of Chemotherapy With/Without Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Population-based Target Trial Emulation Study.
Anticancer Res
Lin CY, Lin YS, Fang HY, Wang CC, Liang JA, Li CC, Chien CR.
PMID: 42203356 [PubMed - indexed for MEDLINE]
Dual Modality and Site-differentiated Sentinel Node Mapping in Vulvar Cancer.
Anticancer Res
Morgenstern B, Schmidt M, Thangarajah F.
PMID: 42203323 [PubMed - indexed for MEDLINE]
Value-based pricing of tislelizumab plus chemotherapy versus chemotherapy alone for advanced oesophageal squamous cell carcinoma: a Markov modelling study from the US payer perspective.
BMJ Open
Abdeen AA, Ayer T, Lim F, Shue S, Hur C.
PMID: 42203284 [PubMed - indexed for MEDLINE]
Immunotherapy for early-stage cutaneous squamous cell carcinoma.
J Immunother Cancer
Boutros A, Kuo YJ, Menzies AM, Long GV, Spagnolo F, Pires da Silva I.
PMID: 42203264 [PubMed - indexed for MEDLINE]
Temporal trends in the probability of melanoma diagnosis in four Nordic countries, 1973-1999.
Cancer Causes Control
Moro O, Schopf TR, Veierød MB, Sebastiani G.
PMID: 42201376 [PubMed - indexed for MEDLINE]
Diagnostic and Prognostic Values of PRAME Immunohistochemistry in Acral Lentiginous Melanoma.
Am J Dermatopathol
Triyangkulsri K, Wittayabusarakam N, Smitthisakda S, Sakpuwadol N, Thadanipon K, Phruttinarakorn B, Rutnin S.
PMID: 42200754 [PubMed - as supplied by publisher]
Immune checkpoint inhibitor therapy for treatment of periocular Merkel cell carcinoma: A systematic review of clinical outcomes and safety.
Indian J Ophthalmol
Folk GA, Lee W, Shoji MK.
PMID: 42200733 [PubMed - indexed for MEDLINE]
Interpretable survival modeling integrating nutritional-inflammatory biomarkers in elderly patients with locally advanced esophageal squamous cell carcinoma treated with definitive radiotherapy.
Front Immunol
Zou J, Fan W, Xia X, Zhang M, Han T, Wu Q.
PMID: 42199434 [PubMed - indexed for MEDLINE]
The immune landscape of melanoma microenvironmental crosstalk.
Front Immunol
Yang Q, Yang Q, Xu B, Chen X, Zheng H, Wang M, Zhang W, Wu J, Cheng H.
PMID: 42199415 [PubMed - indexed for MEDLINE]
Evolutionarily Optimized Multi-Scale Gabor Modeling of Directional Lesion Texture in Dermoscopic Images for Interpretable Melanoma Classification.
Diagnostics (Basel)
Santiago-Montero R, Calzada-Ledesma V, Gutiérrez-Hernández DA, Ortiz-Aguilar LM, Mares-Castro A, Xoca-Orozco LA, Flores-Sierra JJ.
PMID: 42196797 [PubMed]
Integrative Bulk and Single-Cell Transcriptomic Analysis Identifies a Hypoxia- and Lipid Metabolism-Related Prognostic Signature in Oral Squamous Cell Carcinoma: A Retrospective Study.
Int J Mol Sci
Zhao L, Wang J, Jiang K, Wang K, Zhang L.
PMID: 42196541 [PubMed - indexed for MEDLINE]
Dynamic Time-Resolved Remodeling of the Immune Microenvironment After Resistance to BRAF/MEK Inhibitors in Melanoma: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies.
Int J Mol Sci
Meng W, Liu Y, Zhang H, Wang M, Mu X, Zhang Z, Tie Y.
PMID: 42196460 [PubMed - indexed for MEDLINE]
Plant-Derived Compounds as Potential Sensitizers to Immunotherapy in Melanoma.
Int J Mol Sci
B, Negrea-Ghiulai R, Suciu L, Racoviceanu R, Atyim E, Jorgovan M, Maksimovic T, Mioc A, Trandafirescu C, , Mioc M.
PMID: 42196415 [PubMed - indexed for MEDLINE]
Circulating Cytokines in Melanoma Prognosis: Current Evidence and Future Perspectives.
Medicina (Kaunas)
Lapeikis I, Urbonas V.
PMID: 42195213 [PubMed - indexed for MEDLINE]
Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma.
Medicina (Kaunas)
Brenner R, Edri HTF, Rouvinov K, Shani Shrem N, Meirovitz A, El-Saied S, Berezhnov I, Ievko A, Turaieva S, Fenig S, Abu Yasin N, Fenig E, Hussany S, Yakobson A, Shalata W.
PMID: 42195135 [PubMed - indexed for MEDLINE]
Teledermoscopy-Assisted Referral for Cutaneous Melanoma: Diagnostic Timeliness, Histopathologic Severity, and Stage at Excision in a Comparative Cohort.
J Clin Med
Grigore R, Mederle AL, Fericean RM, Ilie AC, Hut EF, Badea MA.
PMID: 42194931 [PubMed]
Potential Efficacy of Luteolin in Cutaneous Squamous Cell Carcinoma: A Combined In Vitro and In Vivo Study.
Biomolecules
Guo Y, Wang X, Gao Y, Xu Y, Fang Z, Liu S, Dong H, Luo J, Yan L.
PMID: 42194085 [PubMed - indexed for MEDLINE]
Cytotoxic and Antimelanoma Activity of Selected 3-Methyl-1,6-diazaphenothiazines in Human Melanoma Cells-In Vitro Studies.
Curr Issues Mol Biol
Morak-M, Jele, Rzepka Z, Koch M, Wrze.
PMID: 42193095 [PubMed]
Articles 1 - 20 / 142992
Page 1 of 7150
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy